Healthcare Providers - In it together
Biosimilars are biologic medicines that healthcare providers can prescribe to their patients living with complex chronic diseases such as inflammatory arthritis, certain types of cancer, diabetes, inflammatory bowel disease and Crohn’s disease.
A biosimilar is a medicine that is highly similar and has no clinically meaningful differences in efficacy and safety compared to the original-brand biologic.9
Biosimilars can be offered at a lower cost because biosimilar manufacturers do not have to recreate the original-brand’s research and development. These savings may be reinvested into improving the healthcare system for Canadians.
Healthcare Provider perspective
The Biosimilars Generation has arrived at clinics across Canada where physicians are prescribing a biosimilar to patients living with disabling and life-threatening chronic diseases, including inflammatory arthritis, certain types of cancer, diabetes, inflammatory bowel disease and Crohn’s disease.